Pharmaceutical Group of European Union
The approaching influenza season, combined with the persistence of COVID-19 across Europe, will offer another significant challenge for health systems across Europe. Several expert groups across the globe have warned that this year’s flu season could be more severe than usual, mainly due to lower natural immunity of people as a consequence of the low circulation of the flu virus last year. Moreover, it is expected that the flu virus circulation will return to pre-pandemic levels with the increasing relaxation of COVID-19 mitigation measures. Lastly, there is also the risk of lower flu vaccination uptake due to increased complacency resulting from the extremely low levels of flu circulation last year.
It is therefore urgent to put in place effective vaccination campaigns that can help preventing hospitalisations, ensuring adequate access and uptake of flu vaccines especially for at risk groups.